Project Grant R21EB039965
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Texas at Arlington $378,411 on April 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop super-resolution tomographic imaging technology for deep tissue visualization. The project aims to overcome diffraction limits inherent in existing super-resolution imaging modalities—including super-resolution fluorescence...
- The University of Texas at Tyler received a $481,440 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the "Discovery and Applied Research for Technological Innovations to Improve Human Health" (CFDA 93.286) program. The grant supports the development of novel pseudo-differential algorithms to drastically increase the computational speed and accuracy of biomedical ultrasound imaging and focusing. This research aims to bridge the gap...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Texas at Dallas $499,156 on June 1, 2026, to develop acoustic blood oxygen level dependent (BOLD) imaging technology for noninvasive bedside monitoring of deep brain tissue oxygenation in neonates with hypoxic brain injury. The recipient will design and validate oxygen-responsive ultrasound contrast agents—specifically hemoglobin-filled microbubbles—that function as biosensors to enable real-time,...
- The National Institute of Biomedical Imaging and Bioengineering awarded Texas Christian University $495,541 on August 18, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop metal-doped graphene quantum dots as dual-mode contrast agents combining ultrasound and near-infrared fluorescence imaging. The research will synthesize and optimize biocompatible metal-doped graphene quantum dots to overcome limitations of...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of North Texas $250,000 on August 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to acquire a GPU-accelerated server infrastructure for biomedical research and education. The University of North Texas will procure a Dell PowerEdge XE9680 rack server equipped with eight NVIDIA HGX H100 80GB SXM5 GPUs to support research and...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of North Texas $134,902 on April 5, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to deliver a summer research program for high school science teachers in the Dallas-Fort Worth region. The University of North Texas places ten high school teachers in active digital health and AI research laboratories where they conduct structured...
- The National Institute of Biomedical Imaging and Bioengineering awarded Virginia Polytechnic Institute & State University $750,993 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop accurate, robust, and practical pulse-echo speed-of-sound imaging methods for clinical ultrasound applications. The project combines physics-based inversion and deep learning approaches to enable two-dimensional,...
- The National Institute of General Medical Sciences awarded the University of North Texas $249,200 on July 1, 2026, through the Biomedical Research and Research Training program (CFDA 93.859) to acquire a Fujifilm VisualSonics VEVO F2 LT high-resolution ultrasound imaging system for small-animal research. The system will establish centralized ultrasound imaging capabilities at the university's vivarium, enabling real-time, non-invasive in vivo cardiac and tumor imaging across small-animal...
- The National Institute of Biomedical Imaging and Bioengineering awarded the University of Texas at Dallas $486,805 on July 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop margination-mediated delivery and glutathione-triggered release mechanisms enabled by renal-clearable gold nanoparticles for fluorescence-guided surgery of brain metastases. The project addresses a clinical gap: current...
- The National Institute of Biomedical Imaging and Bioengineering awarded The University of Texas Southwestern Medical Center $536,853 on September 1, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The award funds development and validation of a comprehensive 7 Tesla MRI framework for simultaneous high-resolution mapping of brain iron and myelin in mesoscale brain structures. The project integrates three complementary...
The National Institute of Biomedical Imaging and Bioengineering awarded the University of Texas at Dallas $186,674 on August 7, 2026, under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to develop fullwave physics-informed recurrent neural networks for ultrasound simulation, quantitative imaging, and adaptive focusing. The project addresses barriers to clinical adoption of quantitative ultrasound by developing a single interpretable model that embeds a differentiable solution of the nonlinear heterogeneous acoustic wave equation into a recurrent neural network. The framework delivers three tightly linked capabilities: rapid forward simulation of nonlinear propagation for artifact-aware sequence design; quantitative inversion to recover speed-of-sound and attenuation maps under realistic conditions; and adaptive focusing to optimize transmit phase and apodization through heterogeneous tissue layers. Aim 1 develops a stable recurrent model of the nonlinear full-wave equation with multi-relaxation attenuation and perfectly matched layers, validated against a trusted solver with a target of 10× GPU speedup. Work is performed in Richardson, Texas. The period of performance runs from award date through June 30, 2029. The assistance type is a Project Grant, which under this program supports hypothesis-, design-, technology-, or device-driven research related to discovery, design, development, validation, and application of technologies for biomedical imaging and bioengineering.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $186.7k | 8/5/26 |